Skip to menu Skip to content Skip to footer

Developing a drug lead to target a new and abundant immune cell (2018)

Experts

Dr Jeffrey Mak

Research Fellow
Institute for Molecular Bioscience
Jeffrey Mak
Jeffrey Mak